ArticleFrontiers in pharmacology2024

A real-world disproportionality analysis of Tivozanib data mining of the public version of FDA adverse event reporting system.

Kaixuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.